Employees Retirement System Of Texas Seagen Inc. Transaction History

Employees Retirement System Of Texas

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$191.51 - $216.16 $27.4 Million - $30.9 Million	-143,000 Reduced 88.27%	19,000 $4.03 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $4.23 Million - $5.01 Million	36,000 Added 28.57%	162,000 $20.8 Million
Q3 2022 Nov 09, 2022	BUY	$135.27 - $180.11 $17 Million - $22.7 Million	126,000 New	126,000 $17.2 Million
Q4 2021 Feb 15, 2022	SELL	$142.57 - $190.86 $5.93 Million - $7.94 Million	-41,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $3.71 Million - $5.15 Million	-27,000 Reduced 39.36%	41,600 $5.78 Million
Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $11.3 Million - $14.5 Million	68,600 New	68,600 $12 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.